Second-trimester maternal serum screening for Down's syndrome: Free β-human chorionic gonadotrophin (HCG) and α-fetoprotein, with or without unconjugated oestriol, compared with total HCG, α-fetoprotein and unconjugated oestriol

Human Reproduction

Volumn 13, Issue 1, 1998, Pages 220-223

  Extermann, Philippe ^a   Bischof, Paul ^a   Marguerat, Philippe ^b   Mermillod, Bernadette ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Down's syndrome; Free HCG; Maternal serum screening; Unconjugated oestriol; fetoprotein

Indexed keywords

ALPHA FETOPROTEIN; CHORIONIC GONADOTROPIN; ESTRIOL;

ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DOWN SYNDROME; FEMALE; FETUS; HEALTH CARE COST; HUMAN; MAJOR CLINICAL STUDY; PRENATAL CARE; PRENATAL SCREENING; RISK; SCREENING TEST; SECOND TRIMESTER PREGNANCY;

EID: 0031906919     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/13.1.220     Document Type: Article

References (14)

1. Crossley, J.A., Aitken, D.A. and Connor, J.M. (1993) Second-trimester unconjugated oestriol levels in maternal serum from chromosomally abnormal pregnancies using an optimized assay. Prenat. Diagn., 13, 271-280.
2. Cuckle, H. and Lilford, R. (1992) Antenatal screening for Down's syndrome. Br.Med. J., 305, 1017.
3. Kellner, L.H., Weiner, Z., Weiss, R.R. et al. (1995) Triple marker (alphafetoprotein, unconjugated estriol, human chorionic gonadotrophin) versus alpha-fetoprotein plus free-beta-subunit in second-trimester maternal serum screening for fetal Down syndrome: a prospective comparison study. Am. J. Obstet. Gynecol., 173, 1306-1313.
4. Macintosh, M.C.M., Iles, R., Teisner, B. et al. (1994) Maternal serum human chorionic gonadotrophin and pregnancy-associated plasma protein A, markers for fetal Down syndrome at 8-14 weeks. Prenat. Diagn., 14, 203-208.
5. Macri, J.N., Kasturi, R.V., Krantz, D.A. et al. (1990a) Maternal serum Down syndrome screening: unconjugated estriol is not useful. Am. J. Obstet. Gynecol., 162, 672-673.
6. Macri, J.N., Kasturi, R.V., Krantz, D.A. et al. (1990b) Maternal serum Down syndrome screening: free beta-protein is a more effective marker than human chorionic gonadotropin. Am. J. Obstet. Gynecol., 163, 1248-1253.
7. Macri, J.N., Spencer, K., Garver, K. et al. (1994J Maternal serum free betaHCG screening: results of studies including 480 cases of Down's syndrome. Prenat. Diagn., 14, 97-103.
8. Milunsky, A., Nebiolo, L.M. and Bellet, D. (1993) Maternal screening for chromosome defects: human chorionic gonadotropin versus its free-beta subunit. Fetal Diagn. Ther., 8, 221-224.
9. Ryall, R.G., Staples, A.J., Robertson, E.F. et al. (1992) Improved performance in a prenatal screening programme for Down's syndrome incorporating serum-free HCG subunit analyses. Prenat. Diagn., 12, 251-261.
10. Spencer, K. and Carpenter, P. (1993) Prospective study of prenatal screening for Down's syndrome with free beta human chorionic gonadotropin. Br. Med. J., 307, 764-769.
11. Spencer, K., Coombes, E.J., Mallard, A.S. et al. (1992) Free beta human choriogonadotropin in Down's syndrome screening: a multicentre study of its role compared with other biochemical markers. Ann. Clin. Biochem., 29, 506-518.
12. Stone, S., Henley, R., Reynolds, T. et al. (1993) A comparison of total and free beta-HCG assays in Down's syndrome screening. Prenat. Diagn., 13, 535-537.
13. Wald, N.J., Cuckle, H.S., Densem, J.W. et al. (1988) Maternal serum screening for Down's syndrome in early pregnancy. Br. Med. J., 297, 883-887.
14. Wald, N., Densem, J., Stone, R. et al. (1993) The use of free β-HCG in antenatal screening for Down's syndrome. Br. J. Obstet. Gynaecol., 100, 550-557.